S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68

IQ-AI (IQAI) Share Forecast, Price & News

GBX 3.90
0.00 (0.00%)
(As of 05/20/2022 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
207,818 shs
Average Volume
455,575 shs
Market Capitalization
£7.12 million
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive IQAI News and Ratings via Email

Sign-up to receive the latest news and ratings for IQ-AI and its competitors with MarketBeat's FREE daily newsletter.

IQ-AI logo

About IQ-AI

IQ-AI Limited, through its subsidiaries, develops software applications for the healthcare industry in Jersey and the United States. Its products include IB Clinic, a toolkit of post-processing software plug-ins for integrating into existing medical image visualization applications; IB Rad Tech, a workflow engine that processes customized workflows; IB Neuro, which analyzes MR data sets and generates parametric perfusion maps quantifying changes in contrast over time; and IB Delta Suite that performs a various fundamental radiology operations, including image co-registration, subtraction, class map generation, and export. The company also offers IB DCE, which analyzes conventional T1 weighted images and generates an array of relevant perfusion and permeability parameters; IB Diffusion that analyzes MR diffusion-weighted images and generates apparent diffusion coefficient, extrapolated b-value, IVIM, and other parameter maps; and StoneChecker, a medical software tool to aid clinical decision making by providing information about a patient's kidney stone. In addition, it provides consulting services. The company was formerly known as Flying Brands Limited and changed its name to IQ-AI Limited in October 2018. IQ-AI Limited is based in Saint Helier, Jersey.


See More Headlines

Industry, Sector and Symbol

Health Information Services
Year Founded

Sales & Book Value

Annual Sales
£521.07 thousand
Cash Flow
GBX 0.38 per share
Book Value
GBX 0.70 per share


Pretax Margin




Free Float
Market Cap
£7.12 million
Not Optionable


Overall MarketRank

0.88 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

IQ-AI (LON:IQAI) Frequently Asked Questions

Who are IQ-AI's key executives?
IQ-AI's management team includes the following people:
  • Mr. Trevor Edward Brown M.B.A., CEO & Director (Age 76, Pay $100k)
  • Mr. David W. J. Smith, Chief Operating Officer
  • Donald Reid, Sec.
What other stocks do shareholders of IQ-AI own?

Based on aggregate information from My MarketBeat watchlists, some companies that other IQ-AI investors own include Macerich (MAC), Merck & Co., Inc. (MRK), Pfizer (PFE), Scotts Miracle-Gro (SMG), Xilinx (XLNX), Arista Networks (ANET), Amgen (AMGN), Advanced Micro Devices (AMD), Akers Biosciences (AKER) and Aimmune Therapeutics (AIMT).

What is IQ-AI's stock symbol?

IQ-AI trades on the London Stock Exchange (LON) under the ticker symbol "IQAI."

How do I buy shares of IQ-AI?

Shares of IQAI and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is IQ-AI's stock price today?

One share of IQAI stock can currently be purchased for approximately GBX 3.90.

How much money does IQ-AI make?

IQ-AI has a market capitalization of £7.12 million and generates £521.07 thousand in revenue each year.

How many employees does IQ-AI have?

IQ-AI employs 7 workers across the globe.

What is IQ-AI's official website?

The official website for IQ-AI is www.imagingbiometrics.com.

This page was last updated on 5/22/2022 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.